Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…
HOME > March 14, 2023
Daily News
March 14, 2023
- Bayer Setting Out to Cut Up to 480 Jobs as Xarelto Patent Cliff Looms: Employee
March 14, 2023
- Japan’s Non-COVID Jab Market to Surpass 180 Billion Yen by 2030: Fuji Keizai
March 14, 2023
- PMDA Sets Target Duration of SaMD Priority Reviews to 6 Months in FY2024 Plan
March 14, 2023
- Over 20% of All Generics under Restricted Shipments: FPMAJ
March 14, 2023
- Moderna, Tohoku University Link Up for Next-Gen Healthcare
March 14, 2023
- Shionogi Inks Malaria Drug Collab with Nagasaki University, MMV
March 14, 2023
Japan’s pharmaceutical industry could be on the verge of gaining a stronger voice in the Central Social Insurance Medical Council…
Let’s face it: in today’s world, changing jobs is a normal part of a successful career. But if it’s so normal, why does it feel so hard? For many people, the idea of leaving their current role brings a heavy…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…